Showing 1 - 10 of 1,945
observed price differences in the market for prescription drugs. The model also predicts free-riding in DTC advertising …This article studies the pricing and advertising of prescription drugs in a duopoly market. If advertising is banned …, decisions of the prescribing physician are price-sensitive. The emerging market equilibrium is characterized by marginal …
Persistent link: https://www.econbiz.de/10005086830
Drug Policy of 1986
Persistent link: https://www.econbiz.de/10009323735
Modifications to Drug Policy 1986
Persistent link: https://www.econbiz.de/10009250151
Pharmaceutical Policy of 2002 covering issues of pricing, ,marketing, size of market, quality, production, investment, regulatory authority, monitoring, ethical issues
Persistent link: https://www.econbiz.de/10009250530
Persistent link: https://www.econbiz.de/10005705057
market structure and market size, focusing on the competitive roles of the endogenous sunk costs of advertising and …> <i>ZUSAMMENFASSUNG - (Werbung, FuE und Marktstruktur in der pharmazeutischen Industrie) <br> Jüngere Entwicklungen der … Konzentration und Marktgröße aus. Dabei wird insbesondere der Einfluß endogener versunkener Kosten für Werbung und/oder Forschung …
Persistent link: https://www.econbiz.de/10005772867
Persistent link: https://www.econbiz.de/10008520728
We investigate whether measures of intangible capital based on advertising and R&D can explain variation in Tobin’s Q …
Persistent link: https://www.econbiz.de/10005463603
We study effects of direct-to-consumer advertising (DTCA) in a mar- ket with two pharmaceutical firms providing … reduces the physicians™ market power and thus detailing expenses, while, on the other, it triggers price competition as a … larger share of patients are aware of the alternatives. Secondly, under price regulation DTCA is welfare improving as long as …
Persistent link: https://www.econbiz.de/10005695847
We study effects of direct-to-consumer advertising (DTCA) in a market with two pharmaceutical firms providing …, DTCA reduces the physicians’ market power and thus detailing expenses, while, on the other, it triggers price competition … as a larger share of patients are aware of the alternatives. Secondly, under price regulation DTCA is welfare improving …
Persistent link: https://www.econbiz.de/10008914353